Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiovascular Diseases | 15 | 2017 | 628 | 1.770 |
Why?
|
Mississippi | 24 | 2017 | 107 | 0.960 |
Why?
|
Middle Aged | 54 | 2023 | 9642 | 0.840 |
Why?
|
Blood Pressure | 10 | 2021 | 613 | 0.790 |
Why?
|
Pharmacists | 2 | 2021 | 53 | 0.790 |
Why?
|
Public Health Administration | 1 | 2020 | 25 | 0.770 |
Why?
|
Aged | 45 | 2021 | 6448 | 0.770 |
Why?
|
Workload | 1 | 2020 | 22 | 0.740 |
Why?
|
Pharmacy | 1 | 2020 | 26 | 0.730 |
Why?
|
Obesity | 7 | 2020 | 965 | 0.710 |
Why?
|
Adult | 47 | 2021 | 11034 | 0.710 |
Why?
|
Students, Pharmacy | 1 | 2020 | 37 | 0.690 |
Why?
|
Hypertension | 8 | 2021 | 770 | 0.680 |
Why?
|
Humans | 73 | 2023 | 34853 | 0.660 |
Why?
|
Female | 57 | 2021 | 19873 | 0.640 |
Why?
|
Tobacco Use Cessation | 1 | 2017 | 13 | 0.620 |
Why?
|
Male | 55 | 2021 | 18870 | 0.600 |
Why?
|
Aged, 80 and over | 25 | 2021 | 2333 | 0.590 |
Why?
|
Cholesterol, HDL | 4 | 2014 | 87 | 0.590 |
Why?
|
Risk Factors | 23 | 2017 | 3414 | 0.580 |
Why?
|
Young Adult | 22 | 2021 | 4012 | 0.580 |
Why?
|
Social Class | 6 | 2013 | 228 | 0.550 |
Why?
|
Christianity | 1 | 2015 | 7 | 0.530 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2017 | 790 | 0.510 |
Why?
|
Triglycerides | 4 | 2014 | 129 | 0.510 |
Why?
|
Cohort Studies | 16 | 2021 | 1422 | 0.500 |
Why?
|
United States | 11 | 2022 | 3894 | 0.470 |
Why?
|
Diabetes Mellitus | 5 | 2015 | 465 | 0.470 |
Why?
|
Insulin Resistance | 4 | 2012 | 177 | 0.460 |
Why?
|
Prevalence | 12 | 2017 | 1425 | 0.450 |
Why?
|
Body Mass Index | 10 | 2018 | 775 | 0.440 |
Why?
|
Students | 1 | 2017 | 452 | 0.430 |
Why?
|
Lung | 2 | 2014 | 413 | 0.430 |
Why?
|
Coronary Artery Bypass | 3 | 2017 | 43 | 0.420 |
Why?
|
Hormone Replacement Therapy | 1 | 2011 | 41 | 0.410 |
Why?
|
Weight Loss | 2 | 2023 | 124 | 0.400 |
Why?
|
Menopause | 1 | 2011 | 54 | 0.400 |
Why?
|
Glucose Intolerance | 1 | 2011 | 42 | 0.400 |
Why?
|
Magnesium | 2 | 2021 | 95 | 0.390 |
Why?
|
Quality of Life | 2 | 2018 | 459 | 0.380 |
Why?
|
Biomedical Research | 3 | 2022 | 371 | 0.360 |
Why?
|
Coronary Disease | 1 | 2010 | 113 | 0.350 |
Why?
|
Life Style | 2 | 2023 | 288 | 0.350 |
Why?
|
Multivariate Analysis | 7 | 2020 | 570 | 0.350 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2015 | 46 | 0.340 |
Why?
|
Cross-Sectional Studies | 12 | 2023 | 2561 | 0.340 |
Why?
|
Health Promotion | 1 | 2015 | 588 | 0.340 |
Why?
|
Coronary Artery Disease | 3 | 2016 | 147 | 0.330 |
Why?
|
Environment | 1 | 2009 | 130 | 0.330 |
Why?
|
Louisiana | 4 | 2023 | 39 | 0.310 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2009 | 214 | 0.300 |
Why?
|
Blood Glucose | 4 | 2014 | 333 | 0.290 |
Why?
|
Prospective Studies | 10 | 2017 | 1353 | 0.280 |
Why?
|
Sleep | 3 | 2021 | 122 | 0.280 |
Why?
|
Cardiotonic Agents | 2 | 2017 | 35 | 0.280 |
Why?
|
Atrial Fibrillation | 2 | 2017 | 105 | 0.260 |
Why?
|
Stress, Psychological | 4 | 2016 | 541 | 0.260 |
Why?
|
Health Status Disparities | 5 | 2019 | 583 | 0.260 |
Why?
|
Retrospective Studies | 8 | 2021 | 1961 | 0.260 |
Why?
|
Regression Analysis | 4 | 2020 | 429 | 0.250 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2021 | 592 | 0.240 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 4 | 2017 | 63 | 0.240 |
Why?
|
Exercise | 3 | 2020 | 524 | 0.240 |
Why?
|
Echocardiography | 4 | 2015 | 144 | 0.230 |
Why?
|
Hospitalization | 2 | 2011 | 370 | 0.230 |
Why?
|
Minority Health | 2 | 2022 | 81 | 0.220 |
Why?
|
Adolescent | 8 | 2021 | 5035 | 0.210 |
Why?
|
Population Surveillance | 4 | 2014 | 231 | 0.210 |
Why?
|
Research Design | 4 | 2018 | 292 | 0.200 |
Why?
|
Program Development | 2 | 2015 | 225 | 0.200 |
Why?
|
Intra-Abdominal Fat | 2 | 2012 | 39 | 0.200 |
Why?
|
Pharmaceutical Services | 1 | 2021 | 22 | 0.200 |
Why?
|
Breast Neoplasms | 1 | 2011 | 1426 | 0.190 |
Why?
|
Genetic Loci | 2 | 2010 | 70 | 0.190 |
Why?
|
Insulin | 2 | 2012 | 224 | 0.180 |
Why?
|
Longitudinal Studies | 8 | 2012 | 841 | 0.180 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2014 | 160 | 0.180 |
Why?
|
Vulnerable Populations | 1 | 2020 | 132 | 0.170 |
Why?
|
Primary Health Care | 2 | 2020 | 283 | 0.170 |
Why?
|
Behavioral Research | 1 | 2019 | 37 | 0.170 |
Why?
|
Calcium | 1 | 2021 | 445 | 0.160 |
Why?
|
C-Reactive Protein | 2 | 2010 | 147 | 0.160 |
Why?
|
Urban Population | 2 | 2010 | 318 | 0.160 |
Why?
|
Prenatal Diagnosis | 1 | 2018 | 10 | 0.160 |
Why?
|
Minority Groups | 2 | 2022 | 537 | 0.160 |
Why?
|
Patient Education as Topic | 2 | 2020 | 207 | 0.160 |
Why?
|
Prenatal Care | 1 | 2018 | 74 | 0.150 |
Why?
|
Incidence | 4 | 2015 | 882 | 0.150 |
Why?
|
Circadian Rhythm | 3 | 2016 | 212 | 0.150 |
Why?
|
Universities | 2 | 2017 | 363 | 0.150 |
Why?
|
Diastole | 2 | 2021 | 46 | 0.140 |
Why?
|
Sex Factors | 4 | 2012 | 859 | 0.140 |
Why?
|
Rural Population | 3 | 2018 | 253 | 0.140 |
Why?
|
Healthcare Disparities | 1 | 2020 | 446 | 0.140 |
Why?
|
Obesity, Abdominal | 2 | 2014 | 26 | 0.140 |
Why?
|
Cholesterol | 1 | 2017 | 194 | 0.140 |
Why?
|
Risk | 4 | 2018 | 256 | 0.140 |
Why?
|
Postoperative Care | 1 | 2015 | 18 | 0.140 |
Why?
|
Postoperative Complications | 1 | 2017 | 206 | 0.140 |
Why?
|
Organizational Objectives | 1 | 2015 | 30 | 0.130 |
Why?
|
Nicotine | 1 | 2017 | 238 | 0.130 |
Why?
|
Telemedicine | 1 | 2018 | 163 | 0.130 |
Why?
|
Prognosis | 3 | 2015 | 707 | 0.130 |
Why?
|
Insecticide-Treated Bednets | 1 | 2014 | 5 | 0.120 |
Why?
|
Mosquito Control | 1 | 2014 | 8 | 0.120 |
Why?
|
Infant Care | 1 | 2014 | 2 | 0.120 |
Why?
|
Personnel, Hospital | 1 | 2014 | 10 | 0.120 |
Why?
|
Health Surveys | 3 | 2014 | 358 | 0.120 |
Why?
|
Infant, Newborn, Diseases | 1 | 2014 | 18 | 0.120 |
Why?
|
Electrocardiography | 2 | 2013 | 154 | 0.120 |
Why?
|
Case-Control Studies | 4 | 2021 | 1056 | 0.120 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 41 | 0.120 |
Why?
|
Hypokalemia | 1 | 2013 | 11 | 0.120 |
Why?
|
Heart Conduction System | 1 | 2013 | 14 | 0.120 |
Why?
|
Quality Assurance, Health Care | 1 | 2014 | 55 | 0.120 |
Why?
|
Infant Mortality | 1 | 2014 | 57 | 0.120 |
Why?
|
Death, Sudden, Cardiac | 2 | 2013 | 19 | 0.120 |
Why?
|
Malaria | 1 | 2014 | 68 | 0.120 |
Why?
|
Proteinuria | 1 | 2013 | 48 | 0.120 |
Why?
|
Chromosome Mapping | 2 | 2010 | 159 | 0.120 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2011 | 88 | 0.110 |
Why?
|
Parenting | 1 | 2013 | 109 | 0.110 |
Why?
|
Allostasis | 1 | 2012 | 10 | 0.110 |
Why?
|
Refusal to Participate | 1 | 2012 | 3 | 0.110 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2012 | 1 | 0.110 |
Why?
|
Persuasive Communication | 1 | 2011 | 7 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2012 | 53 | 0.100 |
Why?
|
Public Health Practice | 1 | 2011 | 38 | 0.100 |
Why?
|
Disease Progression | 2 | 2015 | 580 | 0.100 |
Why?
|
Spirometry | 1 | 2011 | 33 | 0.100 |
Why?
|
Income | 1 | 2012 | 135 | 0.100 |
Why?
|
Prejudice | 1 | 2012 | 101 | 0.100 |
Why?
|
Age Factors | 2 | 2012 | 1007 | 0.100 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 66 | 0.100 |
Why?
|
Motivation | 1 | 2015 | 415 | 0.100 |
Why?
|
Adiponectin | 1 | 2011 | 52 | 0.100 |
Why?
|
Models, Biological | 1 | 2014 | 642 | 0.100 |
Why?
|
Educational Status | 1 | 2012 | 295 | 0.100 |
Why?
|
Health Education | 1 | 2013 | 304 | 0.100 |
Why?
|
Sodium Channels | 1 | 2011 | 63 | 0.100 |
Why?
|
Pericardium | 1 | 2010 | 15 | 0.090 |
Why?
|
Health Status Indicators | 2 | 2007 | 73 | 0.090 |
Why?
|
Ghana | 3 | 2014 | 27 | 0.090 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 44 | 0.090 |
Why?
|
Research Personnel | 2 | 2022 | 133 | 0.090 |
Why?
|
Patient Compliance | 1 | 2011 | 202 | 0.090 |
Why?
|
Geographic Information Systems | 1 | 2010 | 37 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2010 | 109 | 0.090 |
Why?
|
Long QT Syndrome | 1 | 2009 | 12 | 0.090 |
Why?
|
Echocardiography, Doppler | 1 | 2009 | 39 | 0.090 |
Why?
|
Adaptation, Psychological | 2 | 2013 | 358 | 0.090 |
Why?
|
Public Policy | 1 | 2009 | 31 | 0.090 |
Why?
|
Professional Competence | 1 | 2009 | 34 | 0.090 |
Why?
|
Health Services | 1 | 2009 | 53 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2009 | 42 | 0.080 |
Why?
|
Cholesterol, LDL | 1 | 2009 | 63 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2009 | 104 | 0.080 |
Why?
|
Phenotype | 2 | 2009 | 650 | 0.080 |
Why?
|
Lipids | 1 | 2010 | 222 | 0.080 |
Why?
|
Workplace | 1 | 2009 | 72 | 0.080 |
Why?
|
Needs Assessment | 1 | 2010 | 159 | 0.080 |
Why?
|
Attitude | 1 | 2009 | 97 | 0.080 |
Why?
|
Genome, Human | 1 | 2009 | 112 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 4 | 2013 | 528 | 0.080 |
Why?
|
Residence Characteristics | 3 | 2005 | 301 | 0.080 |
Why?
|
Schools | 1 | 2009 | 229 | 0.080 |
Why?
|
Proteins | 1 | 2010 | 352 | 0.080 |
Why?
|
Health Literacy | 2 | 2020 | 100 | 0.080 |
Why?
|
Health Behavior | 1 | 2011 | 491 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2012 | 638 | 0.080 |
Why?
|
Linkage Disequilibrium | 3 | 2012 | 58 | 0.070 |
Why?
|
Smoking | 1 | 2014 | 903 | 0.070 |
Why?
|
Systole | 2 | 2021 | 65 | 0.070 |
Why?
|
Waist Circumference | 3 | 2012 | 82 | 0.070 |
Why?
|
Laboratories | 1 | 2004 | 36 | 0.060 |
Why?
|
Arteriosclerosis | 1 | 2004 | 35 | 0.060 |
Why?
|
Logistic Models | 3 | 2013 | 894 | 0.060 |
Why?
|
Genome-Wide Association Study | 3 | 2010 | 271 | 0.060 |
Why?
|
Feedback | 1 | 2023 | 46 | 0.060 |
Why?
|
Patient Selection | 1 | 2005 | 154 | 0.060 |
Why?
|
Research | 1 | 2004 | 159 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 1003 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 77 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2014 | 871 | 0.050 |
Why?
|
Focus Groups | 1 | 2023 | 307 | 0.050 |
Why?
|
Pregnancy | 3 | 2018 | 1503 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2012 | 151 | 0.050 |
Why?
|
Actigraphy | 1 | 2021 | 12 | 0.050 |
Why?
|
Qualitative Research | 1 | 2023 | 393 | 0.050 |
Why?
|
Sex Distribution | 2 | 2013 | 212 | 0.050 |
Why?
|
Diet, Reducing | 1 | 2020 | 22 | 0.050 |
Why?
|
Hospitals | 1 | 2021 | 86 | 0.050 |
Why?
|
Time Factors | 2 | 2015 | 1681 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 152 | 0.040 |
Why?
|
Research Support as Topic | 1 | 2019 | 75 | 0.040 |
Why?
|
Computers, Handheld | 1 | 2018 | 6 | 0.040 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 14 | 0.040 |
Why?
|
Linear Models | 2 | 2009 | 253 | 0.040 |
Why?
|
Nigeria | 1 | 2018 | 74 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2019 | 158 | 0.040 |
Why?
|
Rural Health Services | 1 | 2018 | 39 | 0.040 |
Why?
|
Genotype | 2 | 2011 | 641 | 0.040 |
Why?
|
Perioperative Care | 1 | 2017 | 5 | 0.040 |
Why?
|
Patient Participation | 1 | 2018 | 68 | 0.040 |
Why?
|
Interviews as Topic | 2 | 2011 | 356 | 0.040 |
Why?
|
Cultural Competency | 1 | 2018 | 120 | 0.040 |
Why?
|
Self Care | 1 | 2018 | 150 | 0.040 |
Why?
|
Internet | 1 | 2018 | 204 | 0.040 |
Why?
|
Comorbidity | 2 | 2011 | 606 | 0.040 |
Why?
|
Child | 2 | 2014 | 2875 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2016 | 59 | 0.030 |
Why?
|
Forecasting | 1 | 2016 | 124 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2018 | 254 | 0.030 |
Why?
|
Poverty | 1 | 2018 | 316 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2016 | 210 | 0.030 |
Why?
|
Hospitals, District | 1 | 2014 | 2 | 0.030 |
Why?
|
World Health Organization | 1 | 2014 | 30 | 0.030 |
Why?
|
Delphi Technique | 1 | 2013 | 22 | 0.030 |
Why?
|
Maryland | 1 | 2014 | 53 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2014 | 49 | 0.030 |
Why?
|
International Cooperation | 1 | 2014 | 44 | 0.030 |
Why?
|
Inservice Training | 1 | 2014 | 30 | 0.030 |
Why?
|
Insecticides | 1 | 2014 | 47 | 0.030 |
Why?
|
Psychological Theory | 1 | 2013 | 23 | 0.030 |
Why?
|
Social Support | 1 | 2016 | 356 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 142 | 0.030 |
Why?
|
Cause of Death | 1 | 2014 | 154 | 0.030 |
Why?
|
Lung Diseases | 1 | 2014 | 56 | 0.030 |
Why?
|
Mentors | 1 | 2014 | 111 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 727 | 0.030 |
Why?
|
Child Development | 1 | 2013 | 84 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2016 | 901 | 0.030 |
Why?
|
Alleles | 1 | 2013 | 284 | 0.030 |
Why?
|
Program Evaluation | 1 | 2014 | 316 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2012 | 68 | 0.030 |
Why?
|
Gene Frequency | 1 | 2012 | 155 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2012 | 90 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2015 | 964 | 0.030 |
Why?
|
Radiography | 1 | 2012 | 75 | 0.030 |
Why?
|
Curriculum | 1 | 2013 | 237 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2011 | 39 | 0.030 |
Why?
|
Overweight | 1 | 2014 | 233 | 0.030 |
Why?
|
Pilot Projects | 1 | 2013 | 628 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2011 | 53 | 0.030 |
Why?
|
Osteopetrosis | 1 | 1991 | 3 | 0.030 |
Why?
|
Awareness | 1 | 2011 | 59 | 0.020 |
Why?
|
Tibia | 1 | 1991 | 18 | 0.020 |
Why?
|
Body Composition | 1 | 2012 | 146 | 0.020 |
Why?
|
Fasting | 1 | 2011 | 50 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 33 | 0.020 |
Why?
|
Lipid Metabolism Disorders | 1 | 2010 | 3 | 0.020 |
Why?
|
Trust | 1 | 2012 | 119 | 0.020 |
Why?
|
Pregnancy, Multiple | 1 | 1990 | 6 | 0.020 |
Why?
|
Infant | 1 | 2014 | 1014 | 0.020 |
Why?
|
Twins | 1 | 1990 | 16 | 0.020 |
Why?
|
Odds Ratio | 1 | 2012 | 517 | 0.020 |
Why?
|
Aortic Diseases | 1 | 2010 | 26 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2010 | 30 | 0.020 |
Why?
|
Genetics, Population | 1 | 2010 | 66 | 0.020 |
Why?
|
Censuses | 1 | 2010 | 24 | 0.020 |
Why?
|
Fetal Blood | 1 | 1990 | 47 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 1990 | 78 | 0.020 |
Why?
|
Calcinosis | 1 | 2010 | 56 | 0.020 |
Why?
|
Child, Preschool | 1 | 2014 | 1318 | 0.020 |
Why?
|
Diabetic Angiopathies | 1 | 2009 | 20 | 0.020 |
Why?
|
Heart Rate | 1 | 2011 | 248 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 137 | 0.020 |
Why?
|
Demography | 1 | 2010 | 167 | 0.020 |
Why?
|
Albuminuria | 1 | 2010 | 76 | 0.020 |
Why?
|
Markov Chains | 1 | 2009 | 32 | 0.020 |
Why?
|
Health Status | 1 | 2012 | 356 | 0.020 |
Why?
|
Oxygen | 1 | 1990 | 193 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 206 | 0.020 |
Why?
|
Myocardium | 1 | 2011 | 224 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2008 | 15 | 0.020 |
Why?
|
Databases, Factual | 1 | 2010 | 288 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2010 | 131 | 0.020 |
Why?
|
Software | 1 | 2010 | 204 | 0.020 |
Why?
|
Genetic Variation | 1 | 2009 | 328 | 0.020 |
Why?
|
Heart Failure | 1 | 2009 | 230 | 0.020 |
Why?
|
Psychometrics | 1 | 2007 | 292 | 0.020 |
Why?
|
Depression | 1 | 2012 | 664 | 0.020 |
Why?
|
Research Subjects | 1 | 2005 | 31 | 0.020 |
Why?
|
HIV Infections | 1 | 2012 | 2207 | 0.010 |
Why?
|
Bone Resorption | 1 | 1991 | 7 | 0.010 |
Why?
|
Osteoclasts | 1 | 1991 | 13 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1991 | 78 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1991 | 138 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1991 | 186 | 0.010 |
Why?
|
Apgar Score | 1 | 1990 | 5 | 0.010 |
Why?
|
Labor Presentation | 1 | 1990 | 2 | 0.010 |
Why?
|
Bicarbonates | 1 | 1990 | 12 | 0.010 |
Why?
|
Cesarean Section | 1 | 1990 | 53 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1991 | 528 | 0.010 |
Why?
|
Mice | 1 | 1991 | 5668 | 0.000 |
Why?
|
Animals | 1 | 1991 | 14307 | 0.000 |
Why?
|